Skip to main content

Day: December 16, 2020

Kvika banki hf. completes auction of bills

Kvika banki hf. has concluded an offering of  three, six and nine months bills in new series. Total offers for bills in the auction amounted to ISK 2,320 million and offers were accepted for ISK 600 million in the series KVB 21 0322 at a simple rate of 1,20%, ISK 600 million in the series KVB 21 0621 at a simple rate of 1,60% and ISK 820 million in the series KVB 21 0921 at a simple rate of 1,80%. The bills are scheduled to be admitted to trading on Nasdaq Iceland in next week.

Continue reading

Kvika banki hf. lýkur víxlaútboði

Kvika banki hf. hefur lokið útboði á þriggja, sex og níu mánaða víxlum í nýjum víxlaflokkum. Í heildina bárust tilboð að fjárhæð 2.320 milljónir kr. og var tilboðum tekið fyrir 600 milljónir í KVB 21 0322 á 1,20% flötum vöxtum, 600 milljónir í KVB 21 0621 á 1,60% flötum vöxtum og 820 milljónir í KVB 21 0921 á 1,80% flötum vöxtum. Áætlað er að taka víxlana til viðskipta á Nasdaq Ísland í næstu viku.

Continue reading

AB Science will host a live webcast on December 17, 2020 on masitinib results in Alzheimer’s Disease

 AB SCIENCE WILL HOST A LIVE WEBCAST ON THURSDAY DECEMBER 17, 2020 ON MASITINIB RESULTS IN ALZHEIMER’S DISEASEParis, December 16, 2020, 6pm CETAB Science SA (NYSE Euronext – FR0010557264 – AB) will host a live webcast on December 17, 2020 with key opinion leaders to discuss recently reported results from the Phase 2B/3 masitinib trial in Alzheimer’s Disease.The webcast will feature presentations by four Key Opinion Leaders:Bruno Dubois, MD (Neurological Institute of the Salpêtrière University Hospital, Paris)Philip Scheltens, MD, PhD (Alzheimer Center at the VU University Medical Center, Amsterdam)Jeffrey L. Cummings, MD (Chamber-Grundy Center for Transformative Neuroscience at UNLV, Las Vegas)Olivier Hermine, MD, PhD (Hospital Necker Paris, France), president of AB Science scientific committee and member of the French Académie des SciencesAB...

Continue reading

AB Science tiendra une conférence virtuelle le 17 décembre 2020 sur les résultats du masitinib dans la maladie d’Alzheimer

AB SCIENCE TIENDRA UNE CONFERENCE VIRTUELLE SUR LES RESULTATS DU MASITINIB DANS LA MALADIE D’ALZHEIMER LE JEUDI 17 DECEMBRE 2020Paris, 16 décembre 2020, 18hAB Science SA (NYSE Euronext – FR0010557264 – AB) annonce qu’elle tiendra une conférence virtuelle le 17 décembre 2020, avec la participation d’intervenants scientifiques de référence, afin de présenter et de discuter des résultats de l’étude de phase 2B/3 évaluant le masitinib dans la maladie d’Alzheimer.Cette conférence virtuelle sera animée par quatre intervenants scientifiques de référence :Bruno Dubois, MD (Institut neurologique du CHU de la Salpêtrière, Paris)Philip Scheltens, MD, PhD (Centre médical universitaire VU, Amsterdam)Jeffrey L. Cummings, MD (Chamber-Grundy Center for Transformative Neuroscience à l’UNLV, Las Vegas)Olivier Hermine, MD, PhD (Hôpital...

Continue reading

Gentherm to Participate in Virtual 19th Annual J.P. Morgan Tech/Auto Forum

NORTHVILLE, Mich., Dec. 16, 2020 (GLOBE NEWSWIRE) — Gentherm (NASDAQ:THRM), a global market leader and developer of innovative thermal management technologies, today announced that Phil Eyler, President and CEO, will participate in a virtual fireside chat at the 19th Annual J.P. Morgan Tech/Auto Forum on Tuesday, January 12, 2021. The presentation will begin at 12:25 pm PT (3:25 pm ET).There will be a live audio webcast of the presentation and a replay will be available for 45 days following the presentation on the Events page of the Investor Relations section of Gentherm’s website at www.gentherm.com.    Investor ContactYijing Brentanoinvestors@gentherm.com 248.308.1702Media ContactMelissa Fischermedia@gentherm.com 248.289.9702

Continue reading

Wolters Kluwer completes acquisition of eOriginal

 Wolters Kluwer completes acquisition of eOriginalDecember 16, 2020 — Wolters Kluwer today announces that it has completed the acquisition of eOriginal, as originally announced on December 10, 2020.—About Wolters KluwerWolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the healthcare; tax and accounting; governance, risk and compliance; and legal and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services. Wolters Kluwer reported 2019 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide. The company is headquartered in Alphen aan den...

Continue reading

Workday Global Study: Organizations Forecast Spike in Digital Revenue as CEOs Champion Digital Initiatives

One-in-Three Executives Project 75% of Revenue to Come from Digital in Next Three Years;Forecast Triples Since 2019 StudyPLEASANTON, Calif., Dec. 16, 2020 (GLOBE NEWSWIRE) — Workday, Inc. (NASDAQ:WDAY), a leader in enterprise cloud applications for finance and human resources, today released initial findings of its global executive survey “Organizational Agility: Roadmap to Digital Acceleration” exploring the state of digital initiatives and organizational agility.In a year that started with a global health crisis triggering economic and geopolitical disruption, agility became a defining hallmark for success, according to the study. Workday surveyed more than 1,000 C-suite executives and business leaders to identify key challenges and opportunities across the offices of the CEO, chief financial officer (CFO), chief human resources...

Continue reading

Physical Rehabilitation Network Acquires Northern California-Based Health-Pro Physical Therapy, Inc.

Carlsbad, California, Dec. 16, 2020 (GLOBE NEWSWIRE) — Physical Rehabilitation Network (PRN) of Carlsbad, Calif., today announced its acquisition of Health-Pro Physical Therapy, Inc. Northern California-based Health-Pro Physical Therapy, Inc. is comprised of two traditional physical therapy and massage therapy clinics, located in Walnut Creek and Concord, California. The addition of the Health-Pro Physical Therapy, Inc. clinics into the PRN organization brings PRN’s Northern California count to 11 and national clinic count to 138 clinics.Health-Pro Physical Therapy, Inc. was founded in Walnut Creek, California by Sandy Schall, PT in 2004. In 2014, Schall expanded Health-Pro Physical Therapy with the addition of the Concord clinic to better serve the greater East Bay Area. Both clinics offer a variety of services including orthopedic...

Continue reading

Production report for November 2020

           Oslo, 16 December 2020Below please find average gross operated production in November 2020 and corresponding numbers for October 2020.Barrels of oil equivalents per dayBarrels of oil per dayOperated by Selva Maria Oil on behalf of IOX until local authorities approves operator’s licence.CommentsThere were no major changes in total production from October to November. Oil production in Argentina increased slightly, but output continues to be affected by weak markets and challenging logistics.There were no new covid-19 infections reported among Interoil personnel during November.As mentioned in the October production report, a minor oil spill occurred at the Vikingo field in Colombia. It had no significant impact on output. Clean-up after the spill was effectuated immediately. Remediation work will be completed when new topsoil...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.